EGFR and head and neck cancer: Head and neck cancer is also known to express high levels of EGFR with a strong prognostic value, and the ‘drugable’ relevance of this growth factor has been reported by others (Pomerantz and Grandis, 2003, 2004) and us (Dassonville et al, 1993; Etienne et al, 1999; Pivot et al, 2005).